GNMX

Aevi Genomic Medicine Inc
GNMX

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

GNMX was delisted on the 3rd of February, 2020.

Back to rankings

28 hedge funds and large institutions have $6.12M invested in Aevi Genomic Medicine Inc in 2019 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

Holders
28
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$32.7K
2
+$27K
3
+$18.9K
4
LTFS
Ladenburg Thalmann Financial Services
Florida
+$16.1K
5
VF
Virtu Financial
New York
+$12.2K

Top Sellers

1
-$70.6K
2
-$24K
3
-$19K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$5.33M
2
$382K
3
$156K
4
$100K
5
$29K
6
$27K
7
$24K
8
$24K
9
$17K
10
$7K
11
$7K
12
$4K
13
$4K
14
$3K
15
$2K
16
$2K
17
$2K
18
$1K
19
$10
20
$1
21
–
22
–